SAN ANTONIO, Dec. 17 /PRNewswire/ -- Interim results of the Phase II XeNA (Xeloda in NeoAdjuvant) trial suggest that the combination of oral Xeloda(R) (capecitabine) and Taxotere(R) (docetaxel), with ...

Aegon N.V. AEG recently announced that it has closed the combination deal for its Dutch pension, life and non-life insurance, banking, as well as mortgage origination operations with its peer a.s.r., ...

Novel BCL2 inhibitor sonrotoclax monotherapy demonstrates deep and durable clinical responses in R/R MCL and R/R CLLSonrotoclax in combination with BRUKINSA demonstrated rapid MRD negativity in ...

- Preliminary safety and efficacy data from Phase 1b firstMIND trial in patients with newly diagnosed diffuse large B-cell lymphoma (DLBCL) presented today - Also presented today: Long-term subgroup ...

Wayne-based Toys R Us Inc.‘s new strategy to house both its Toys R Us and Babies R Us brands under a single roof puts the company at the front of an emerging shift in retail toward maximizing ...

ROCKVILLE, Md. and SUZHOU, China, Dec. 10, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to ...